Evidence map›Paper›PMID 24510468›Full record

ReviewMolecular nutrition & food research2014

Molecular targets of isothiocyanates in cancer: recent advances.

Parul Gupta, Bonglee Kim, Sung-Hoon Kim, Sanjay K Srivastava

Open access · greenAbstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. In Silico and In Vitro Analysis of Sulforaphane Anti-Antibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Isothiocyanate-Rich Extracts from Cauliflower (International journal of environmental research and public health · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Glucosinolate Bioactivation byBiomolecules · 2021
    Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Parul GuptaDepartment of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Bonglee Kim
Sung-Hoon Kim
Sanjay K Srivastava
Kyung Hee University · KRTexas Tech University Health Sciences Center · US

Funding

Chemoprevention of Pancreatic Cancer by CapsaicinR01CA129038 · NCI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI SRIVASTAVA, SANJAY K. · 2009 to 2013
$1.5M
Role of Nuclear Factor kappa Beta in Activity of BITC against Pancreatic CancerR01CA106953 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SRIVASTAVA, SANJAY K. · 2004 to 2008
$1.5M
Medical Research Council 2007-0054931NCI NIH HHS CA106953NCI NIH HHS CA129038NCI NIH HHS R01 CA106953NCI NIH HHS R01 CA129038
6 · The paper itself

Abstract

Cancer is a multistep process resulting in uncontrolled cell division. It results from aberrant signaling pathways that lead to uninhibited cell division and growth. Various recent epidemiological studies have indicated that consumption of cruciferous vegetables, such as garden cress, broccoli, etc., reduces the risk of cancer. Isothiocyanates (ITCs) have been identified as major active constituents of cruciferous vegetables. ITCs occur in plants as glucosinolate and can readily be derived by hydrolysis. Numerous mechanistic studies have demonstrated the anticancer effects of ITCs in various cancer types. ITCs suppress tumor growth by generating reactive oxygen species or by inducing cycle arrest leading to apoptosis. Based on the exciting outcomes of preclinical studies, few ITCs have advanced to the clinical phase. Available data from preclinical as well as available clinical studies suggest ITCs to be one of the promising anticancer agents available from natural sources. This is an up-to-date exhaustive review on the preventive and therapeutic effects of ITCs in cancer.

Indexed as

Dietary SupplementsModels, BiologicalAnimalsAnticarcinogenic AgentsAntineoplastic Agents, PhytogenicBiomedical ResearchHumansIsothiocyanatesNeoplasmsAnticarcinogenic AgentsAntineoplastic Agents, PhytogenicIsothiocyanatesBITCCancerIsothiocyanatePEITCSulforaphane

Identifiers

PMID24510468
PMCPMC4122603
OpenAlexW1965750166

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.